The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Hydroxychloroquine study withdrawn over data concerns 

Hydroxychloroquine
The anti-malaria drug has been touted as a “miracle cure” for Covid-19, but the scientific evidence so far is confusing. Associated Press

Authors have withdrawn an influential article finding that hydroxychloroquine had no benefit against Covid-19, citing data concerns.

The article, published in the Lancet medical journal on May 22, was by Harvard Medical School, the University of Utah and Switzerland’s University Hospital Zurich. It found that antimalarial drugs hydroxychloroquine and a similar drug chloroquine showed no benefit against Covid-19 and could even increase the risk of heart arrhythmia and death.

But three of the four authors, including Frank Ruschitzka of the University Hospital of Zurich, have now retracted it.

On Thursday, they said that Surgisphere, the company that provided the data, would not transfer the dataset for an independent review and that they “can no longer vouch for the veracity of the primary data sources”. The fourth author of the study, Sapan Desai who is chief executive of Surgisphere, declined to comment on the retraction, according to Reuters.  

In a June 5 update to its original press release, Zurich University Hospital department of cardiology said it was “only called in by Harvard Medical School to co-author the paper during the evaluation phase” and “was not involved in the provision of the data by the company Surgisphere or in the evaluation of the data collection”. “Prof. Ruschitzka had no contact with the company,” it adds. “After reservations became known, the authors immediately requested an external audit.” 

Controversy 

The antimalarial drug has been surrounded by controversy. Claimed by French professor Didier Raoult to be a miracle cure for the new coronavirus, it has also been touted by US President Donald Trump and Brazilian President Jair Bolsonaro. The Lancet article caused the suspension of several studies into its use for Covid-19. 

At the height of the pandemic in March, Swiss hospitals all had their own policies with regard to administration of the drug, according to data gathered by Swiss television RTS. In mid-May most of the big hospitals harmonised their practise, deciding to stop using chloroquine to treat Covid-19 except for patients taking part in clinical trials. 

The World Health Organization paused hydroxychloroquine trials after The Lancet study was released but said on Wednesday it was ready to resume trials.

Popular Stories

Most Discussed

News

A live scarecrow competition to thrill Denens (VD)

More

Live scarecrow competition set to thrill Swiss

This content was published on The Fête de l'Epouvantail (scarecrow festival) is celebrating its 30th anniversary and returns to Denens in canton Vaud for its seventh edition from July 10-20.

Read more: Live scarecrow competition set to thrill Swiss
Man dies in accident on toboggan run in Matten near Interlaken BE

More

Man dies on Swiss toboggan run

This content was published on A 35-year-old man has died in a work accident at the valley station of the Heimwehfluh toboggan run in Matten near Interlaken, canton Bern.

Read more: Man dies on Swiss toboggan run
The Swiss embassy in Tehran reopens

More

Swiss embassy in Tehran re-opens

This content was published on The Swiss embassy in Tehran re-opened on Sunday after being closed on June 20 owing to the unstable situation in the country.

Read more: Swiss embassy in Tehran re-opens
Queen of the Netherlands attends European Championship match in Lucerne

More

Euro 2025: Dutch queen cheers on team in Lucerne

This content was published on Queen Maxima of the Netherlands and her youngest daughter Princess Ariane attended the Netherlands' women's European Championship football match against Wales in Switzerland on Saturday.

Read more: Euro 2025: Dutch queen cheers on team in Lucerne
30-year-old charged with drone flight at Women's European Championships

More

Man charged with flying drone at women’s Euro 2025

This content was published on A man flew a drone around the venue on Wednesday evening during the first match of the Women's EURO 2025 in St. Gallen. The 30-year-old violated the absolute ban on flying during match days. He was reported to the police.

Read more: Man charged with flying drone at women’s Euro 2025
257 Swiss companies are members of the SBTi

More

More than 250 Swiss companies sign CO2 reduction initiative

This content was published on A total of 257 companies from Switzerland have signed up to the Science Based Targets Initiative (SBTi). In doing so, they are committing to CO2 reduction targets that are compatible with the Paris Climate Agreement.

Read more: More than 250 Swiss companies sign CO2 reduction initiative

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR